(Updates)
** Shares of Nanosonics Ltd NAN.AX surge as much as 27.7%
to A$7.52, their biggest intraday pct gain since Aug 27, 2019
** Nanosonics, which manufactures and distributes ultrasound
probe disinfectors, says annual revenue up 3% at A$103.1 mln
($74.30 mln) urn:newsml:reuters.com:*:nASX1Gb6jQ
** NAN anticipates a return to double-digit growth in total
revenue in FY22, as ultrasound procedures return to pre-COVID19
levels
** Citi expects NAN to benefit from normalisation of
ultrasound procedures in FY22, although short-term risks due to
COVID-19 exist
** NAN's reported FY21 NPAT of A$8.6 mln beats Citi estimate
of A$5.8 mln
** Citi expects FY22 core net profit of A$20.7 mln, and A$29
mln in FY23
** As at 0530 GMT, Nanosonics top gainer in the ASX 200
benchmark index .AXJO
** Stock at its highest since Feb. 8; posts eighth straight
session of gains
** About 6.2 mln shares change hands, vs the 30-day average
volume of ~599,000 shares
($1 = 1.3875 Australian dollars)
(Reporting by Harish Sridharan and Dhriti Garg in Bengaluru)
((harish.sridharan@thomsonreuters.com))